Literature DB >> 23783049

Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.

Ryan P Kopp1, Lejla Aganovic, Kerrin L Palazzi, Fiona H Cassidy, Kyoko Sakamoto, Ithaar H Derweesh.   

Abstract

INTRODUCTION: To further elucidate potential patterns of contrast enhancement for renal neoplasm subtypes, we investigated utility of contrast washout formula to differentiate renal tumor histology after multiphase computerized tomography (CT).
MATERIALS AND METHODS: Single center retrospective cohort study of 163 patients with multiphase CT for renal masses obtained October 2007 to July 2012. Pathology confirmed clear cell (CC-RCC; n = 92), papillary (Pa-RCC; n = 43), chromophobe (Ch-RCC; n = 6), oncocytoma (OC; n = 11), or angiomyolipoma (AML; n = 11) histology. Two radiologists in consensus and blinded to histology recorded tumor size, morphology, and attenuation measurements in Hounsfield Units (HU). Data were analyzed between subgroups based on histology. Enhancement washout of the tumor was calculated by the formula (Mass nephrographic HU-Mass delayed HU)/(Mass nephrographic HU-Mass non-contrast HU) and used to calculate sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).
RESULTS: Tumor size was largest among CC-RCC (p < 0.001). Homogeneous composition was more common among Pa-RCC and Ch-RCC (p < 0.001). Median washout for Ch-RCC (0.27) was significantly different from that of OC (0.54, p = 0.05). Overall 25 (15.3%) of tumors had washout < 0. Tumors with washout value < 0 were Pa-RCC 24/43 (56%), and Ch-RCC 1/6 (14%). Washout value < 0 had a specificity of 99.2% for Pa-RCC and 100% for non-CC-RCC. Washout value ≥ 0 had a sensitivity and NPV of 100% for CC-RCC, OC, and AML. Washout value ≥ 0 had a specificity of 35.2% and a PPV of 66.7% for CC-RCC.
CONCLUSIONS: Enhancement washout value < 0 is highly specific for Pa-RCC and non-CC-RCC. Washout value ≥ 0 is highly sensitive for CC-RCC, OC, and AML while there was a significant difference in median washout between OC and Ch-RCC. Further prospective investigation is requisite to confirm these findings.

Entities:  

Mesh:

Year:  2013        PMID: 23783049

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  6 in total

1.  Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.

Authors:  Alp Tuna Beksac; Gerant Rivera-Sanfeliz; Catherine A Dufour; Unwanaobong Nseyo; Zachary Hamilton; Sean W Berquist; Abd-elRahman Hassan; Omer A Raheem; Song Wang; Robert W Wake; Robert E Gold; Ithaar H Derweesh
Journal:  World J Urol       Date:  2016-08-02       Impact factor: 4.226

2.  Effect of phase of enhancement on texture analysis in renal masses evaluated with non-contrast-enhanced, corticomedullary, and nephrographic phase-enhanced CT images.

Authors:  Kathleen Nguyen; Nicola Schieda; Nick James; Matthew D F McInnes; Mark Wu; Rebecca E Thornhill
Journal:  Eur Radiol       Date:  2020-09-10       Impact factor: 5.315

3.  Can multiphase CT scan distinguish between papillary renal cell carcinoma type 1 and type 2?

Authors:  Ahmet Bindayi; Michelle L Mcdonald; Alp T Beksac; Gerant Rivera-Sanfeliz; Ahmed Shabaik; Fiona Hughes; Lejla Aganovic; Donna E Hansel; Ithaar H Derweesh
Journal:  Turk J Urol       Date:  2018-07

4.  Initial Evaluation of Computer-Assisted Radiologic Assessment for Renal Mass Edge Detection as an Indication of Tumor Roughness to Predict Renal Cancer Subtypes.

Authors:  Rahul Rajendran; Kevan Iffrig; Deepak K Pruthi; Allison Wheeler; Brian Neuman; Dharam Kaushik; Ahmed M Mansour; Karen Panetta; Sos Agaian; Michael A Liss
Journal:  Adv Urol       Date:  2019-04-23

5.  Multi-Phase Multiple Detector Computed Tomography (MDCT) Enhancement Patterns and Morphological Features of Chromophobe Renal Cell Carcinoma: An Analysis of 67 Cases.

Authors:  Min Luo; Yuting Zhu; Shaobin Chen; Qilin Huang; Wei Zhang; Mingping Ma; Yongbao Wei
Journal:  Med Sci Monit       Date:  2021-04-28

6.  Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.

Authors:  Claudia-Gabriela Moldovanu; Bianca Petresc; Andrei Lebovici; Attila Tamas-Szora; Mihai Suciu; Nicolae Crisan; Paul Medan; Mircea Marian Buruian
Journal:  Medicina (Kaunas)       Date:  2020-10-28       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.